He has expertise in the use of endoscopic endonasal approaches and minimally invasive surgery to treat benign and malignant skull base lesions and complex brain tumors including pituitary adenomas, Rathke’s cleft cysts, epidermoid cysts, pineal region tumors, meningiomas, schwannomas, chordomas, chondrosarcomas, craniopharyngiomas, paranasal sinuses tumor, and olfactory neuroblastomas. Dr. Beer Furlan’s unique experience and extensive training in open conventional approaches and minimally invasive techniques allows him to provide all surgical treatment options in an unbiased manner. His focus is to select the safest, most effective, and less invasive approach for each individual patient. Dr. Beer Furlan research interests include patient’s quality of life and outcomes after endoscopic endonasal and keyhole surgical approaches, prognostic biomarkers for skull base tumors, and super selective endovascular drug delivery for brain cancers.